Researchers discover cell differentiation mechanism

Researchers from the Haematopoietic Differentiation and Stem Cell Biology group at the Centre for Genomic Regulation (CRG), have described one of the mechanisms by which a cell (from the skin, for example) can be converted into another which is completely different (e.g., a neurone or hepatic cell). They have discovered that the cell transcription factor C/EBPa is a determinant factor in cell transdifferentiation. This differentiation mechanism can be applied to any of the cells of an organism. The scope of the study, published in the Proceedings of the Natural Academy of Sciences (PNAS), could profoundly influence the development of cell therapies.

In all tissues, stem cells specialise to produce very different cell types. This specialisation is, to a great extent, regulated by transcription factors, proteins responsible for activating or repressing the transcription of various genes. The study of these factors is essential for understanding how a stem cell is converted into a specialised cell as well as the reverse path, that is, how a specialised cell is converted into a stem cell. This process, which reveals all the steps of specialisation, is known as dedifferentiation.

This reversal of the cell differentiation process had already been described in skin cells by a group of Japanese researchers, and cases of skin cells being converted into cardiac cells, neurones and liver cells (hepatocytes) have been reported. However, until now it hadn't been possible to see if, during this process, the cell was reconverted into a stem cell for later specialisation, or if it simply transformed into another cell. This process of direct transformation is what is known as transdifferentiation (see photo 1).

Investigators from the CRG, led by Thomas Graf, research professor at the ICREA, have studied this process for years. In this research they used immune system cells and saw that it was possible to convert a leukocyte (white blood cell) into a macrophage (cells which engulf and digest any foreign particle), without the need to reconvert into a stem cell, that is, following the reverse specialisation pathway. The results of this research show that dedifferentiation and transdifferentiation are completely different processes.

The scope of these findings is currently restricted to the fields of research and academia, but they will be relevant for the development of treatments with cell therapy. The possibility of obtaining cells of any type at the moment that they are required is getting nearer all the time.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Barcoding small extracellular vesicles with new CRISPR-based system